Literature DB >> 1324474

Ellipticine increases the superhelical density of intracellular SV40 DNA by intercalation.

Y Chu1, M T Hsu.   

Abstract

We investigated the in vivo effect of ellipticine, a mammalian topoisomeraseII(topoII) inhibitor, on SV40 DNA topology. In contrast to epipodophyllotoxins, ellipticine did not cause significant double stranded cleavage of intracellular SV40 DNA. Furthermore, ellipticine reduced cleavage induced by epipodophyllotoxins, VP16 and VM26. Unexpectedly, ellipticine dramatically increased the superhelical density of a fraction of intracellular SV40 DNA. Several lines of evidence suggest that the formation of this highly supercoiled DNA species (Ih form DNA) is not due to the inhibition of topoII per se, but is the result of intercalation by ellipticine in a subfraction of the intracellular SV40 chromatin followed by the fixation of DNA linking number by a topoisomerase activity. Based on the linking number change and the known unwinding angle of ellipticine, the intercalation density was calculated as one ellipticine molecule per 10-20 bp in the Ih DNA. This result suggests the existence of different populations of intracellular SV40 chromatin with respect to the accessibility to ellipticine intercalation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324474      PMCID: PMC334084          DOI: 10.1093/nar/20.15.4033

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  The structure of DNA in a nucleosome.

Authors:  J J Hayes; T D Tullius; A P Wolffe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Biochemical and ultrastructural analysis of SV40 chromatin.

Authors:  W Keller; U Müller; I Eicken; I Wendel; H Zentgraf
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

3.  Structure of nucleosome core particles of chromatin.

Authors:  J T Finch; L C Lutter; D Rhodes; R S Brown; B Rushton; M Levitt; A Klug
Journal:  Nature       Date:  1977-09-01       Impact factor: 49.962

4.  Helical repeat of DNA in solution.

Authors:  J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

5.  Intercalative binding of ellipticine to DNA.

Authors:  K W Kohn; M J Waring; D Glaubiger; C A Friedman
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

6.  Evidence for variation of supercoil densities among simian virus 40 nucleoprotein complexes and for higher supercoil density in replicating complexes.

Authors:  S S Chen; M T Hsu
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

7.  Interaction of an ultimate carcinogen, benzo[a]pyrene diol epoxide, with nucleosomal core particles: apparent lack of protection of DNA by histone proteins.

Authors:  M C MacLeod; B Smith; L K Lew
Journal:  Mol Carcinog       Date:  1989       Impact factor: 4.784

8.  Mapping of sequences with 2-fold symmetry on the simian virus 40 genome: a photochemical crosslinking approach.

Authors:  C K Shen; J E Hearst
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

9.  Reversible and irreversible changes in nucleosome structure along the c-fos and c-myc oncogenes following inhibition of transcription.

Authors:  T A Chen; R Sterner; A Cozzolino; V G Allfrey
Journal:  J Mol Biol       Date:  1990-04-05       Impact factor: 5.469

10.  The higher-order structure of chromatin: evidence for a helical ribbon arrangement.

Authors:  C L Woodcock; L L Frado; J B Rattner
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

View more
  2 in total

Review 1.  The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, Hepatic Cytochrome P450 Reductase Null (HRN™) mice and pure enzymes.

Authors:  Marie Stiborová; Věra Černá; Michaela Moserová; Iveta Mrízová; Volker M Arlt; Eva Frei
Journal:  Int J Mol Sci       Date:  2014-12-25       Impact factor: 5.923

2.  Antitumor Activity of New Olivacine Derivatives.

Authors:  Janusz Piasny; Benita Wiatrak; Agnieszka Dobosz; Beata Tylińska; Tomasz Gębarowski
Journal:  Molecules       Date:  2020-05-28       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.